Table 2 Pathogen co-infected of the participants
From: Clinical features of Mycoplasma pneumoniae pneumonia in children without fever
All (n = 542) | Febrile Group (n = 491) | Afebrile Group (n = 491) | P value | |
|---|---|---|---|---|
Virus | ||||
Epstein-barr virus, % | 61 (11.25) | 60 (12.22) | 1 (1.96) | 0.027 |
Parainfluenza virus, % | 21 (3.87) | 20 (4.07) | 1 (1.96) | 0.717 |
Syncytial virus, % | 14 (2.58) | 14 (2.85) | 0 (0.00) | 0.448 |
Influenza B virus, % | 12 (2.21) | 11 (2.24) | 1 (1.96) | 1.000 |
Rhinovirus, % | 2 (0.37) | 1 (0.20) | 1 (1.96) | 0.449 |
Adenovirus, % | 2 (0.37) | 2 (0.41) | 0 (0.00) | 1.000 |
Boca virus, % | 1 (0.18) | 1 (0.20) | 0 (0.00) | 1.000 |
Metapneumovirus, % | 1 (0.18) | 1 (0.20) | 0 (0.00) | 1.000 |
Bacteria | ||||
Haemophilus influenzae, % | 39 (7.20) | 34 (6.92) | 5 (9.80) | 0.636 |
Streptococcus pneumoniae, % | 29 (5.35) | 24 (4.89) | 5 (9.80) | 0.247 |
Moraxella catarrata, % | 1 (0.18) | 1 (0.20) | 0 (0.00) | 1.000 |
Pseudomonas aeruginosa, % | 1 (0.18) | 1 (0.20) | 0 (0.00) | 1.000 |
Staphylococcus aureus, % | 1 (0.18) | 1 (0.20) | 0 (0.00) | 1.000 |